The third and final Atturos brainstorming session was focussed on Business Development and was held today in NovaUCD. This session brought together a fresh selection of attendees – prominent biotechnology entrepreneurs, innovation managers, and commercialisation leaders from some of the worlds top diagnostics and instrumentation companies. This vibrant group were brought together to share their expertise and discuss Atturos’ commercial strategy.
A number of key factors were discussed in this session; including partnership deals, insurance coverage, collaborations with hospital networks and academic centres, adding value for patients, investment routes, pipeline tests and products, and regulatory paths.
These brainstorming sessions have been invaluable to Atturos’ commercial development, and we look forward to working in tandem with individual attendees to further explore various aspects in more detail.